[AQST] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -44.78%
YoY- 37.30%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 13,206 10,682 11,078 7,149 16,419 16,824 12,195 1.33%
PBT -8,010 -12,352 -28,945 -20,368 -12,636 -13,944 -10,040 -3.69%
Tax 101 5,797 19,020 -1,102 -652 1,135 1,970 -39.03%
NP -8,111 -18,149 -28,945 -20,368 -12,636 -13,944 -10,040 -3.49%
Tax Rate - - - - - - - -
Total Cost 21,317 28,831 40,023 27,517 29,055 30,768 22,235 -0.69%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -61.42 -169.90 -261.28 -284.91 -76.96 -82.88 -82.33 -4.76%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.12 -0.33 -0.72 -0.60 -0.48 -0.56 -0.50 -21.15%
EPS Diluted -0.12 -0.33 -0.72 -0.60 -0.48 -0.56 -0.50 -21.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.